Member Directory
MSD is a trade name of Merck & Co., Inc., with headquarters in Whitehouse Station, NJ, USA. MSD delivers vaccines, medications, and consumer and animal health products that save and improve the lives of millions around the world. MSD offers therapies for the treatment of cardiovascular disease, high blood pressure, elevated cholesterol levels, diabetes, cancer, benign prostatic hypertrophy, asthma and allergies, arthritis, pain, migraine, glaucoma, osteoporosis, women's health, infectious diseases (antibiotic, antifungal, and antiviral agents) and vaccines to prevent childhood diseases, human papilloma virus, rotavirus, shingles, and hepatitis A, B and C. Worldwide product sales in 2011 were $48 billion.
In MultiplAI Health we are developing a liquid biopsy for cardiovascular diseases based on RNA sequencing of the peripheral blood and analyzed through artificial intelligence. We believe that precise cardiovascular medicine can be found in a simple blood test.
Mursla is a startup developing a diagnostic device that leverages proprietary nanostructures to significantly improve cancer detection through the utilization of a novel, non-invasive procedure called liquid biopsy.
My Green Lab’s mission is to build a global culture of sustainability in science and is a world leader in developing environmental standards for laboratories and laboratory products—bringing sustainability solutions to the community responsible for the world’s life-changing medical innovations.
The importance of this effort cannot be overlooked - Laboratories are some of the most resource-intensive buildings of any kind. A typical laboratory can use up to 10x more energy and 4x more water than a typical office building. Additionally, laboratory supply chains are responsible for approximately 2% of worldwide plastic waste, making the scientific community’s efforts to reduce its environmental impact a truly global effort. My Green Lab estimates there are over 265,000 labs worldwide and over 2,000,000 laboratory products, each providing an opportunity for My Green Lab programs and services in an increasingly environmentally conscious and cost-sensitive industry.
As such, My Green Lab’s two flagship programs, Green Lab Certification and ACT Label are designed to address the environmental impact in laboratories and lab supply chains respectively. Each certification program delivers customer value by proving frameworks for scientific organizations to reduce environmental impact, realize cost savings, and create market differentiation for their scientific organizations and/or products.
Since the development of the My Green Lab Certification and ACT Label, My Green Lab as an organization has grown from a grassroots effort to the most influential organization in the laboratory sustainability space. My Green Lab counts 23 of 25 of the world’s largest pharma companies as customers, with more than 1,300 labs and 2,400 products certified across 220 organizations and in 39 countries. With proven market fit, its recent endorsement by the United Nations Race to Zero Program, and a substantial lead on the competition, My Green Lab is positioned for global growth.
MyData-Trust is an international company specialized in Data Protection and exclusively dedicated to the life sciences industry.
The aim of MyData-TRUST consists in providing strategic, operational and organizational support, making important contribution both legally and technically to the success of the Data Protection implementation and the company as a whole. We provide services solutions aligned with both Health R&D and Data Protection requirements: Data Security, GDPR, HIPAA, CCPA.
MyData-TRUST provides adapted and customized services according to the specific situation of each and delivers high quality standards and studied services. All our experts are externally certified in data protection and having a background in the healthcare industry.
NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick Science Park. We are using synthetic biology approaches to develop a completely novel modality for the targeted, intracellular delivery of therapeutic proteins and peptides.
NEB UK supplies a broad range of reagents and kits for basic and applied research at the DNA, RNA and protein levels. These products are also for use in drug development and screening, as well as for use in platform technologies and as raw materials in kit manufacture. We supply standard catalogue products as well as custom and bulk formulations. We would like to partner with you from R&D downstream to market. Call us to discuss your ‘biological component’ needs.
New Path Molecular specialises in the chemical synthesis of complex functional molecules using the cutting edge techniques, methods and instrumentation developed in the laboratories of Prof Steve Ley at the University of Cambridge. Our processes and molecules are being used to validate biological processes and produce products globally.